ClinicalTrials.Veeva

Menu

Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale (PN-PROS)

Boston Children's Hospital logo

Boston Children's Hospital

Status

Completed

Conditions

Obstructive Sleep Apnea
Narcolepsy

Study type

Observational

Funder types

Other

Identifiers

NCT05373979
IRB-A00029346

Details and patient eligibility

About

The purpose of this study is to test a pediatric narcolepsy patient reported outcomes tool to assess pediatric narcolepsy symptoms and their effect on daily functioning and quality of life. The goal is to develop a clinical survey that can improve the care of pediatric narcolepsy.

Full description

WHO IS ELIGIBLE?

  • Children and adolescents with narcolepsy between the ages of 9-17 years
  • Diagnosis must be verified by a signed letter from physician in order to participate
  • Participants must be able to understand the purpose of the study

PARTICIPATION DETAILS

  • Upon enrollment participants will receive an email containing a link to complete HIPAA compliant online surveys about narcolepsy symptoms, quality of life, and daily function. Surveys should take no more than 30 minutes.
  • One week later, some participants will receive another email with a link to complete a 10-minute follow up survey

Enrollment

212 patients

Sex

All

Ages

9 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children and adolescents ages 9-17
  • Have a diagnosis of narcolepsy type 1, narcolepsy type 2, or mild to moderate obstructive sleep apnea (OSA)

Exclusion criteria

  • A history of visual or hearing impairment
  • A co-morbid neurodevelopmental disorder such as autism or schizophrenia
  • No access to computer/tablet/smart phone to complete questionnaires

Trial design

212 participants in 2 patient groups

Narcolepsy
Description:
Narcolepsy type 1 (NT1 or narcolepsy with cataplexy) and Narcolepsy type 2 (NT2 or narcolepsy without cataplexy)
Obstructive Sleep Apnea
Description:
mild to moderate obstructive sleep apnea (OSA; obstructive AHI of 1-15/hour)

Trial contacts and locations

1

Loading...

Central trial contact

Gillian Heckler

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems